![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Invesco Global Listed Private Equity ETF | AMEX:PSP | AMEX | Exchange Traded Fund |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.17 | 0.28% | 61.68 | 61.87 | 61.27 | 61.34 | 47,419 | 18:10:00 |
Personal Screening PLC 09 August 2006 For release Wednesday 9th August 2006 at 07.00 Personal Screening plc NEW STUDY USING THE 'SMOKESCREEN' TEST TO REDUCE SMOKING IN PREGNANCY Personal Screening plc is pleased to announce that its product SmokeScreen has been selected for use in a trial by Aylesbury Primary Care Trust. SmokeScreen, the test for smoking developed by Personal Screening's subsidiary Mermaid Diagnostics Limited, which can be used in doctor's surgeries and hospital clinics, is being used to advise pregnant women about the dangers of smoking to their unborn baby and to themselves. The 5-minute urine test which turns pink, with the heavier smokers turning the darkest colour, can tell the mother how much nicotine and other harmful chemicals from tobacco are getting into her bloodstream and then into her baby. The test is used as an educational tool to help smokers understand more about the damage caused by smoking. Midwives based in Aylesbury, Amersham and Stoke Mandeville in Buckinghamshire are targeting, amongst others, teenage pregnancies. The trial by Bucks Stop Smoking Service, lead by Jane Giles will find out if showing the pregnant mothers the level of their smoking will help them understand why the midwives try so hard to get them to stop smoking. Smoking in pregnancy is the focus of massive health campaigns through the country, and this has contributed to a fall from 20% to 17% of the pregnant population, but in women younger than 20 years old the percentage has increased from 40 to 45%. Jane Giles, the Mid and South Bucks Smoke Free Pregnancy Co-ordinator says "This test is not about seeking out pregnant smokers, but more about motivating and supporting those pregnant smokers who would like to stop smoking but are struggling to do so". Dr Graham Cope, Technical Director of Mermaid, said "Stopping smoking in pregnancy is the best thing a woman can do to ensure a healthier start in life for her baby. I am delighted to work with such an enthusiastic group of midwives, to use SmokeScreen to highlight the dangers of smoking in pregnancy". Information for editors Smoking in pregnancy is the greatest cause of preventable infant mortality and morbidity - increasing of miscarriage and premature birth; and increasing the risk of the baby suffering from chronic lung problems and sudden infant death syndrome (SIDS). Data supplied by the Stop Smoking Service show that: Eighty percent of pregnant smokers would like to stop. Up to a quarter of pregnant women do not tell the midwife that they are smoking, and many of those that do under report the number of cigarettes they use. The SmokeScreen test measures the breakdown chemicals from nicotine, specifically a chemical called cotinine. When a pregnant woman is told her levels of nicotine intake she is 20 times more likely to quit smoking. Contact details Jane Giles, Bucks Stop Smoking Service 0845 27 07 222 Dr Graham Cope, Mermaid Diagnostics Limited 01384 352 717 Chris Steele 020 7034 4759 csteele@adventis.co.uk Adventis Financial PR This information is provided by RNS The company news service from the London Stock Exchange END NRAUWRBRNSRWRAR
1 Year Invesco Global Listed Pr... Chart |
1 Month Invesco Global Listed Pr... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions